Sus Clinicals, Inc.
Biotechnology company · Cincinnati, Ohio, United States
Sus Clinicals, Inc. is a biotechnology company headquartered in Cincinnati, Ohio, United States. Its earliest recorded incorporation is in 2020. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $2 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2024.
Sus Clinicals at a glance
What does Sus Clinicals do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $2 million in total (2023). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $3.5 million sold (2024).
Frequently asked questions about Sus Clinicals
Where is Sus Clinicals headquartered?
Sus Clinicals, Inc. is headquartered in Cincinnati, Ohio, United States.
What does Sus Clinicals do?
Sus Clinicals, Inc. is a biotechnology company.
When was Sus Clinicals founded?
The earliest incorporation on record for Sus Clinicals, Inc. is in 2020, according to public company registers.
Similar companies
- Aerpio Therapeutics, Inc.Cincinnati, Ohio, United States
- P2D, IncCincinnati, Ohio, United States
- Megadyne Medical Products, Inc.Cincinnati, Ohio, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences